These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35197305)

  • 1. Type 1 interferon status in systemic lupus erythematosus: a longitudinal analysis.
    Northcott M; Jones S; Koelmeyer R; Bonin J; Vincent F; Kandane-Rathnayake R; Hoi A; Morand E
    Lupus Sci Med; 2022 Feb; 9(1):. PubMed ID: 35197305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis-derived membrane vesicles drive the cGAS-STING pathway and enhance type I IFN production in systemic lupus erythematosus.
    Kato Y; Park J; Takamatsu H; Konaka H; Aoki W; Aburaya S; Ueda M; Nishide M; Koyama S; Hayama Y; Kinehara Y; Hirano T; Shima Y; Narazaki M; Kumanogoh A
    Ann Rheum Dis; 2018 Oct; 77(10):1507-1515. PubMed ID: 29945921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon Inhibition for Lupus with Anifrolumab: Critical Appraisal of the Evidence Leading to FDA Approval.
    Loncharich MF; Anderson CW
    ACR Open Rheumatol; 2022 Jun; 4(6):486-491. PubMed ID: 35157371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monocyte surface expression of Fcgamma receptor RI (CD64), a biomarker reflecting type-I interferon levels in systemic lupus erythematosus.
    Li Y; Lee PY; Kellner ES; Paulus M; Switanek J; Xu Y; Zhuang H; Sobel ES; Segal MS; Satoh M; Reeves WH
    Arthritis Res Ther; 2010; 12(3):R90. PubMed ID: 20478071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of systemic type I interferon activity with clinical phenotypes, disease activity, and damage accrual in systemic lupus erythematosus in treatment-naive patients: a retrospective longitudinal analysis.
    Miyachi K; Iwamoto T; Kojima S; Ida T; Suzuki J; Yamamoto T; Mimura N; Sugiyama T; Tanaka S; Furuta S; Ikeda K; Suzuki K; Niewold TB; Nakajima H
    Arthritis Res Ther; 2023 Feb; 25(1):26. PubMed ID: 36803843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cluster of highly expressed interferon-stimulated genes associate more with African ancestry than disease activity in patients with systemic lupus erythematosus. A systematic review of cross-sectional studies.
    Siddiqi KZ; Wilhelm TR; Ulff-Møller CJ; Jacobsen S
    Transl Res; 2021 Dec; 238():63-75. PubMed ID: 34343626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between circulating interferon and kynurenine/tryptophan pathway metabolites: support for a novel potential mechanism for cognitive dysfunction in SLE.
    Anderson EW; Jin Y; Shih A; Arazi A; Goodwin S; Roeser J; Furie RA; Aranow C; Volpe B; Diamond B; Mackay M
    Lupus Sci Med; 2022 Nov; 9(1):. PubMed ID: 36384965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Cyclic GMP-AMP Synthase in Patients With Systemic Lupus Erythematosus.
    An J; Durcan L; Karr RM; Briggs TA; Rice GI; Teal TH; Woodward JJ; Elkon KB
    Arthritis Rheumatol; 2017 Apr; 69(4):800-807. PubMed ID: 27863149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum interferon-α2 measured by single-molecule array associates with systemic disease manifestations in Sjögren's syndrome.
    Huijser E; Göpfert J; Brkic Z; van Helden-Meeuwsen CG; Jansen S; Mandl T; Olsson P; Schrijver B; Schreurs MWJ; van Daele PLA; Dik WA; Versnel MA
    Rheumatology (Oxford); 2022 May; 61(5):2156-2166. PubMed ID: 34505866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type I interferon gene signature test-low and -high patients with systemic lupus erythematosus have distinct gene expression signatures.
    Brohawn PZ; Streicher K; Higgs BW; Morehouse C; Liu H; Illei G; Ranade K
    Lupus; 2019 Nov; 28(13):1524-1533. PubMed ID: 31660791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher activation of the interferon-gamma signaling pathway in systemic lupus erythematosus patients with a high type I IFN score: relation to disease activity.
    Liu M; Liu J; Hao S; Wu P; Zhang X; Xiao Y; Jiang G; Huang X
    Clin Rheumatol; 2018 Oct; 37(10):2675-2684. PubMed ID: 29774490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type I interferon signaling in systemic immune cells from patients with alcoholic cirrhosis and its association with outcome.
    Weiss E; Rautou PE; Fasseu M; Giabicani M; de Chambrun M; Wan J; Minsart C; Gustot T; Couvineau A; Maiwall R; Hurtado-Nedelec M; Pilard N; Lebrec D; Valla D; Durand F; de la Grange P; Monteiro RC; Paugam-Burtz C; Lotersztajn S; Moreau R
    J Hepatol; 2017 May; 66(5):930-941. PubMed ID: 28040548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel type I IFN-producing cell subset in murine lupus.
    Lee PY; Weinstein JS; Nacionales DC; Scumpia PO; Li Y; Butfiloski E; van Rooijen N; Moldawer L; Satoh M; Reeves WH
    J Immunol; 2008 Apr; 180(7):5101-8. PubMed ID: 18354236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus.
    Oke V; Gunnarsson I; Dorschner J; Eketjäll S; Zickert A; Niewold TB; Svenungsson E
    Arthritis Res Ther; 2019 Apr; 21(1):107. PubMed ID: 31036046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-302d targets IRF9 to regulate the IFN-induced gene expression in SLE.
    Smith S; Fernando T; Wu PW; Seo J; Ní Gabhann J; Piskareva O; McCarthy E; Howard D; O'Connell P; Conway R; Gallagher P; Molloy E; Stallings RL; Kearns G; Forbess L; Ishimori M; Venuturupalli S; Wallace D; Weisman M; Jefferies CA
    J Autoimmun; 2017 May; 79():105-111. PubMed ID: 28318807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. α-Ketoglutarate-Dependent KDM6 Histone Demethylases and Interferon-Stimulated Gene Expression in Lupus.
    Montano EN; Bose M; Huo L; Tumurkhuu G; De Los Santos G; Simental B; Stotland AB; Wei J; Bairey Merz CN; Suda J; Martins G; Lalani S; Lawrenson K; Wang Y; Parker S; Venuturupalli S; Ishimori M; Wallace DJ; Jefferies CA
    Arthritis Rheumatol; 2024 Mar; 76(3):396-410. PubMed ID: 37800478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of highly active systemic lupus erythematosus by combined type I interferon and neutrophil gene scores vs classical serologic markers.
    Chasset F; Ribi C; Trendelenburg M; Huynh-Do U; Roux-Lombard P; Courvoisier DS; Chizzolini C;
    Rheumatology (Oxford); 2020 Nov; 59(11):3468-3478. PubMed ID: 32375176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of key interferon-stimulated genes for indicating the condition of patients with systemic lupus erythematosus.
    Shen M; Duan C; Xie C; Wang H; Li Z; Li B; Wang T
    Front Immunol; 2022; 13():962393. PubMed ID: 35967341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Cyclin-Dependent Kinase 1 as a Novel Regulator of Type I Interferon Signaling in Systemic Lupus Erythematosus.
    Wu L; Qin Y; Xia S; Dai M; Han X; Wu Y; Zhang X; Ma J; Wang Y; Tang Y; Liu Z; Zhu W; Jallal B; Yao Y; Qu B; Shen N
    Arthritis Rheumatol; 2016 May; 68(5):1222-32. PubMed ID: 26663909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of Cardiometabolic Disease Markers by Type I Interferon Inhibition in Systemic Lupus Erythematosus.
    Casey KA; Smith MA; Sinibaldi D; Seto NL; Playford MP; Wang X; Carlucci PM; Wang L; Illei G; Yu B; Wang S; Remaley AT; Mehta NN; Kaplan MJ; White WI
    Arthritis Rheumatol; 2021 Mar; 73(3):459-471. PubMed ID: 32909675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.